RLMD – relmada therapeutics, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RLMD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/19

09:35 am

rlmd

Rating for RLMD

High Report

Rating for RLMD

Report

11/19

09:35 am

rlmd

Rating for RLMD

High Report

Rating for RLMD

Report

11/19

09:06 am

rlmd

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $10.00 price target on the stock.

Medium Report

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $10.00 price target on the stock.

Report

11/19

09:06 am

rlmd

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $10.00 price target on the stock.

Medium Report

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $10.00 price target on the stock.

Report

11/19

08:32 am

rlmd

Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho

Medium Report

Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho

Report

11/19

08:32 am

rlmd

Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho

Medium Report

Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.